S. Masumoto, H. Inoue; Y. Maruyama, [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)]., in Nihon Yakurigaku Zasshi, vol. 75, n. 5, Lug 1979, pp. 517-25, PMID 44259.
I. Takayanagi, K. Koike, A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs., in Gen Pharmacol, vol. 16, n. 3, 1985, pp. 265-7, PMID 2862092.
K. Kawahara, T. Ofuji, Simultaneous determination of befunolol, a beta-blocking agent, and its metabolite in human plasma by gas chromatography with electron-caputre detection., in J Chromatogr, vol. 168, n. 1, Gen 1979, pp. 266-72, PMID 33199.
A. Ebihara, K. Tawara; T. Oka; T. Ofuji; K. Kawahara, Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration., in Eur J Clin Pharmacol, vol. 23, n. 3, 1982, pp. 189-95, PMID 6129139.
M. Makiura, M. Uyama; H. Sasamoto; M. Mantani; M. Hattori, Ocular hypotensive effects of befunolol to glaucomatous eyes--comparison with pilocarpine, in Nihon Ganka Gakkai Zasshi, vol. 86, n. 6, 1982, pp. 565-72, PMID 6127926.
Y. Shimizu, [Effects of befunolol ophthalmic solution, a beta-adrenergic blocking agent, on ocular hypertension and primary glaucoma]., in Nihon Ganka Gakkai Zasshi, vol. 86, n. 12, Dic 1982, pp. 2123-34, PMID 6132535.
H. Miki, Effect of befunolol ophthalmic solution, alpha, beta-adrenergic blocking agent, on secondary glaucoma, in Nihon Ganka Gakkai Zasshi, vol. 87, n. 1, 1983, pp. 1-13, PMID 6133424.
M. Nino, F. Suppa; F. Ayala; N. Balato, Allergic contact dermatitis due to the beta-blocker befunolol in eyedrops, with cross-sensitivity to carteolol, in Contact Dermatitis, vol. 44, n. 6, Giu 2001, p. 369, PMID 11380552.
V. Zucchelli, S. Silvani; C. Vezzani; S. Lorenzi; A. Tosti, Contact dermatitis from levobunolol and befunolol, in Contact Dermatitis, vol. 33, n. 1, Lug 1995, pp. 66-7, PMID 7493479.
S. Harada, T. Ban; T. Fujita; A. Koshiro, Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents, in Arch Int Pharmacodyn Ther, vol. 252, n. 2, Ago 1981, pp. 262-71, PMID 6118107.